Sanjay Popat, BSc, MBBS, FRCP, PhD, The Royal Marsden NHS Foundation Trust, London, UK, gives his perspective on where immunotherapy for patients with lung cancer will be heading in the next couple of years. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).